Cite
HARVARD Citation
Casanova, M. et al. (n.d.). P519 Analysis of the effectiveness and safety of switching from originator to biosimilar adalimumab in patients with Inflammatory Bowel Disease. Journal of Crohn's and colitis. pp. i474-i475. [Online].